Slayback Pharma's Private Equity Round

Slayback Pharma raised a round of funding on January 06, 2017. Investors include Kohlberg Kravis Roberts & Co..

Slayback is a pharmaceutical company focused on the development of complex generic and specialty pharmaceutical products.…

Articles about Slayback Pharma's Private Equity Round: